Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Receivables (2016 - 2025)

STRATA Skin Sciences' Change in Receivables history spans 14 years, with the latest figure at -$568000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 244.16% year-over-year to -$568000.0; the TTM value through Sep 2025 reached -$965000.0, down 217.43%, while the annual FY2024 figure was $631000.0, 547.52% up from the prior year.
  • Change in Receivables for Q3 2025 was -$568000.0 at STRATA Skin Sciences, up from -$929000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $899000.0 in Q4 2022 and bottomed at -$929000.0 in Q2 2025.
  • The 5-year median for Change in Receivables is -$13000.0 (2021), against an average of $25894.7.
  • The largest annual shift saw Change in Receivables soared 1072.09% in 2023 before it plummeted 414.92% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $309000.0 in 2021, then skyrocketed by 190.94% to $899000.0 in 2022, then plummeted by 129.7% to -$267000.0 in 2023, then surged by 350.19% to $668000.0 in 2024, then tumbled by 185.03% to -$568000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Change in Receivables are -$568000.0 (Q3 2025), -$929000.0 (Q2 2025), and -$136000.0 (Q1 2025).